Voglio sapere a riguardo di…

BILLING CODE 801101P

142601".

e. Removing k1$2,500 capital category as per Rule 15c33 and adding in its place k1Limited business mutual funds and/or variable annuities only in the Claiming an Exemption from Rule 15c33 section.
f. Removing 3. Other accrued withdrawals and adding in its place 3. Other anticipated withdrawals in the Other Capital Withdrawals Recap section.
g. In the Computation of CFTC
Minimum Capital Requirements section, removing v. Enter the sum of Lines A.ii and A.iv. . . . . lll

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration 21 CFR Parts 130 and 131
Docket No. FDA2000P0126 formerly Docket No. 2000P0685
RIN 0910AI40

Milk and Cream Products and Yogurt Products; Final Rule To Revoke the Standards for Lowfat Yogurt and Nonfat Yogurt and To Amend the Standard for Yogurt AGENCY:
ACTION:

174461

174471
vii. Enter the sum of Lines A.ii, A.iv, and A.vi. . . . . $lll
174551"

jbell on DSKJLSW7X2PROD with RULES

Note: The text of Part IIC of Form X17A5 does not, and this amendment will not, appear in the Code of Federal Regulations.

6. Amend Part IIC of Form X17A5
referenced in 249.617 of this chapter by:
a. Removing

"200b, "16631 bl" and "l6636b 17:30 Jun 10, 2021

Jkt 253001

Final rule.

The Food and Drug Administration FDA or we is issuing a final rule to revoke the standards of identity for lowfat yogurt and nonfat yogurt and amend the standard of identity for yogurt in numerous respects. This action is in response, in part, to a citizen petition submitted by the National Yogurt Association NYA.
The final rule modernizes the yogurt standard to allow for technological advances while preserving the basic nature and essential characteristics of yogurt and promoting honesty and fair dealing in the interest of consumers.
DATES: This rule is effective July 12, 2021. The Director of the Federal Register approves the incorporation by reference of certain publications listed in the rule as of July 12, 2021.
The compliance date of this final rule is January 1, 2024. See section X for further information on the filing of objections.
SUMMARY:

vi. If the FCM is also registered as a swap dealer, enter 2% of Line A.v. . . . . $lll
VerDate Sep<11>2014

Food and Drug Administration,
HHS.

and adding in its place:
v. Amount of uncleared swap margin. . . . . $lll
PO 00000

Frm 00031

Fmt 4700

Sfmt 4700

Written/Paper Submissions Submit written/paper submissions as follows:
Mail/Hand Delivery/Courier for written/paper submissions: Dockets Management Staff HFA305, Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper objections submitted to the Dockets Management Staff, FDA will post your objection, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in Instructions.
Instructions: All submissions received must include the Docket No. FDA
2000P0126 for Milk and Cream
E:FRFM11JNR1.SGM

11JNR1

ER11JN21.014 ER11JN21.013

FR Doc. 202111572 Filed 61021; 8:45 am
Electronic Submissions Submit electronic objections in the following way:
Federal eRulemaking Portal:
https www.regulations.gov. Follow the instructions for submitting comments.
Objections submitted electronically, including attachments, to https
www.regulations.gov will be posted to the docket unchanged. Because your objection will be made public, you are solely responsible for ensuring that your objection does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone elses Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your objection, that information will be posted on https www.regulations.gov.
If you want to submit an objection with confidential information that you do not wish to be made available to the public, submit the objection as a written/paper submission and in the manner detailed see Written/Paper Submissions and Instructions.

ER11JN21.012

Dated: May 27, 2021.
Vanessa A. Countryman, Secretary.

ER11JN21.011

@2621 $

respectively.

ER11JN21.010

and adding in its place B. Additions including non-conforming capital of $

"l7206bij" and "l7205bbl",
ER11JN21.009

@263b $ _ _ 142601"

"l7206bl" and "l7205bl"
in Lines 9 and 10 of Column B the Regulatory Capital section and adding in its place
ER11JN21.008

in the Statement of Income Loss or Statement of Comprehensive Income, As Applicable section in a new line immediately preceding the line reading REVENUE.
d. Removing B. Additions including non-conforming capital of $

ER11JN21.007

respectively.
b. Removing
ER11JN21.006

"200bbl", "16631 bij" and 16636bij",
and Number of months included in this statement
Submit either electronic or written objections and requests for a hearing on the final rule by July 12, 2021.
ADDRESSES: You may submit objections and requests for a hearing as follows.
Please note that late, untimely filed objections will not be considered.
Electronic objections must be submitted on or before July 12, 2021. The https
www.regulations.gov electronic filing system will accept comments until 11:59 p.m. Eastern Time at the end of July 12, 2021. Objections received by mail/hand delivery/courier for written/
paper submissions will be considered timely if they are postmarked or the delivery service acceptance receipt is on or before that date.

ER11JN21.005

139321 to _ _ 139331"

in Lines 13.B., 13.B.1. and 13.B.2. of the Balance Sheet section and adding in its place
ER11JN21.004

c. Adding For the period MMDDYY
from

31117

ER11JN21.003

Federal Register / Vol. 86, No. 111 / Friday, June 11, 2021 / Rules and Regulations